GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Akero Therapeutics Inc (STU:0K4) » Definitions » Dividend Yield %

Akero Therapeutics (STU:0K4) Dividend Yield % : 0.00% (As of Apr. 04, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Akero Therapeutics Dividend Yield %?

As of today (2025-04-04), the Trailing Annual Dividend Yield of Akero Therapeutics is 0.00%.

The historical rank and industry rank for Akero Therapeutics's Dividend Yield % or its related term are showing as below:

STU:0K4's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.46
* Ranked among companies with meaningful Dividend Yield % only.

Akero Therapeutics's Dividend Payout Ratio for the three months ended in Dec. 2024 was 0.00.

As of today (2025-04-04), the Forward Dividend Yield % of Akero Therapeutics is 0.00%.

Akero Therapeutics's Dividends per Share for the three months ended in Dec. 2024 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Akero Therapeutics Dividend Yield % Historical Data

The historical data trend for Akero Therapeutics's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akero Therapeutics Dividend Yield % Chart

Akero Therapeutics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Dividend Yield %
Get a 7-Day Free Trial - - - - -

Akero Therapeutics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Akero Therapeutics's Dividend Yield %

For the Biotechnology subindustry, Akero Therapeutics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Akero Therapeutics's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Akero Therapeutics's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Akero Therapeutics's Dividend Yield % falls into.


;
;

Akero Therapeutics Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Akero Therapeutics  (STU:0K4) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Akero Therapeutics Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Akero Therapeutics's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Akero Therapeutics Business Description

Traded in Other Exchanges
Address
601 Gateway Boulevard, Suite 350, South San Francisco, CA, USA, 94080
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.

Akero Therapeutics Headlines

No Headlines